Home › Funds › Bellevue Group AG › EPRX

Bellevue Group AG position in EPRX

EUPRAXIA PHARMACEUTICALS INC · Health Care

Bellevue Group AG reported holding 2,595,139 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$23.6M, representing 0.49% of its reported portfolio and ranking #46 among its reported holdings. Bellevue Group AG first reported this position in Q3 2026.

Latest position (Q3 2026)2.60M sh
Reported value held$23.62M
Portfolio Weight0.49%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's EPRX position evolved

Bellevue Group AG first disclosed a stake in EPRX in Q3 2026 at 2,595,139 shares (US$23.6M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 2.60M $23.62M New

About EPRX and 13F data

EPRX (EUPRAXIA PHARMACEUTICALS INC) is a Health Care company. 72 other funds we track also report a position in EPRX — the largest reported positions include Affinity Asset Advisors, LLC (US$15.6M), Vivo Capital, LLC (US$12.3M), GREAT POINT PARTNERS LLC (US$10.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EPRX

All EPRX fund holders →

FAQ

How long has Bellevue Group AG held EPRX?

Bellevue Group AG has disclosed EPRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Bellevue Group AG's current position in EPRX?

As of Q3 2026, Bellevue Group AG holds 2.60M shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), valued at $23.62M, representing 0.49% of its reported portfolio and ranking #46.

Has Bellevue Group AG been buying or selling EPRX?

In the latest 13F filing (Q3 2026), Bellevue Group AG newly opened its position in EPRX.

Which other funds hold EPRX?

Other major institutional holders of EPRX include Affinity Asset Advisors, LLC, Vivo Capital, LLC, GREAT POINT PARTNERS LLC, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.